Calidi Biotherapeutics (NYSEMKT: CLDI)
$5.29
(5.0%)
$0.25
Price as of August 12, 2025, 4:00 p.m. ET
Calidi Biotherapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Calidi Biotherapeutics Company Info
First Light Acquisition Group Focuses on identifying dual-use, technology-enabled solutions with mission-critical applications in large and rapidly growing markets.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.